1 2 149 "A STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL ON THE EFFICACY OF YOGA AS AN ADJUVANT THERAPY FOR PATIENTS WITH ANKYLOSING SPONDYLITIS AMIDST COVID-19 PANDEMIC". BACKGROUND: AMIDST THE ADVERSITIES OF THE COVID 19 PANDEMIC, THE HEALTH CARE SYSTEM HAS SEEN A NEW PARADIGM SHIFT TOWARDS E-HEALTH SERVICES. IN THE ADVENT OF CATERING TO THE GEOMETRICALLY INCREASING HEALTH CARE NEEDS OF THE PATIENTS SUFFERING FROM VARIOUS CHRONIC HEALTH CONDITIONS WHEN IN SOCIAL ISOLATION, THE NEED FOR THE SHIFT SEEMS TO BE PARAMOUNT. PATIENTS WITH ANKYLOSING SPONDYLITIS UNDER IMMUNOSUPPRESSANTS AND VARIABLE DEGREES OF DISABILITIES ARE AT HIGHER RISK. THIS STUDY AIMS TO ASSESS THE EFFICACY OF E-YOGA AS A TREATMENT OPTION FOR THESE PATIENTS IN NEED. METHODS: THIS IS A SINGLE-CENTER, PARALLEL-GROUP PROSPECTIVE RANDOMIZED, OPEN-BLINDED END-POINT TRIAL. PATIENTS AGED BETWEEN 30 TO 50 YEARS WILL BE RECRUITED FROM THE MEMBERS OF ANTARDHWANI: A SOCIETY OF ANKYLOSING SPONDYLITIS, AHMEDABAD, GUJARAT. THE YOGA EXPERTS WILL ADMINISTER A SCIENTIFICALLY DEVELOPED AND VALIDATED YOGA MODULE VIA E-YOGA MODALITIES. A TOTAL OF 135 PATIENTS WILL BE RECRUITED AND RANDOMLY ALLOCATED TO YOGA AND CONTROL GROUPS. DATA WILL BE RECORDED AT BASELINE AND THREE MONTHS ON DISEASE ACTIVITY, DEGREE OF FUNCTIONAL LIMITATIONS IN PATIENTS, QUALITY OF LIFE, INFLAMMATORY BIOMARKERS, DEPRESSION, AND ANXIETY USING BATH AS DISEASE ACTIVITY INDEX (BASDAI), BATH AS FUNCTIONAL INDEX(BASFI), AS QUALITY OF LIFE INDEX(ASQOL), C REACTIVE PROTEIN (CRP), ERYTHROCYTE SEDIMENTATION RATE (ESR), PHYSICAL HEALTH QUESTIONNAIRE-4 (PHQ-4), RESPECTIVELY. DISCUSSION: THE STUDY WILL REPORT THE EFFICACY OF E-YOGA IN CATERING TO THE PHYSICAL AND MENTAL INSUFFICIENCIES OF INPATIENTS WITH ANKYLOSING SPONDYLITIS AMIDST COVID 19 PANDEMIC. THE STUDY IS PROSPECTIVELY REGISTERED IN THE CLINICAL TRIAL REGISTRY OF INDIA (CTRI/2020/08/027215). 2021 2 1485 34 INTEGRATIVE APPROACH COMBINING AYURVEDA, COUNSELLING, YOGA AND MEDITATION WITH CONVENTIONAL MANAGEMENT OF ANKYLOSING SPONDYLITIS - A CASE REPORT. LIFELONG MEDICATIONS ARE REQUIRED FOR SYMPTOMATIC RELIEF IN ANKYLOSING SPONDYLITIS (AS). WE REPORT THE POTENTIAL OF AN INTEGRATIVE APPROACH IN REDUCING DEPENDENCE ON STEROIDS AND PAIN MEDICATIONS IN CHRONIC AS. A 59-YEAR-OLD HLA-B27 POSITIVE MALE PATIENT SUFFERING FROM AS FOR 40 YEARS SOUGHT AYURVEDIC TREATMENT FOR RELAPSE OF PAIN, STIFFNESS, FATIGUE, INTERMITTENT CONSTIPATION AND DISTURBED SLEEP. AYURVEDIC DIAGNOSIS WAS AMAVATA (A CLINICAL CONDITION CHARACTERISED BY JOINT INFLAMMATION) THE PATIENT WAS MANAGED AS OUTPATIENT FOR ELEVEN DAYS AND HOSPITALISED FOR THIRTY THREE DAYS. INTERNAL MEDICINES AND EXTERNAL THERAPIES WITH DIET MODIFICATION, LIFESTYLE ADJUSTMENTS, COUNSELLING, YOGA AND IAM TECHNIQUE (INTEGRATED AMRITA MEDITATION TECHNIQUE ) WERE ADMINISTERED DURING THE HOSPITAL STAY. AT YEARLY FOLLOW UP, C-REACTIVE PROTEIN WAS REDUCED TO 15.7 MG/L FROM THE BASELINE VALUE OF 37.5 MG/L, AND ESR FROM 103 MM/H TO 8 MM/H INDICATING REDUCTION IN INFLAMMATION. THE DOSE OF NSAID AND DMARD (DISEASE MODIFYING ANTIRHEUMATIC DRUG) COULD BE REDUCED FROM ONCE IN TWENTY-FOUR HOURS TO ONCE IN EIGHTY-FOUR HOURS AND STEROIDS FROM TWICE DAILY TO ONCE IN A WEEK. THERE WAS SIGNIFICANT REDUCTION IN PAIN AND STIFFNESS. INTEGRATION OF AYURVEDA AND YOGA WITH CONVENTIONAL TREATMENT CAN REDUCE DRUG DEPENDENCE AND IMPROVE QUALITY OF LIFE IN AS. 2022 3 1143 27 ELDERLY-CUSTOMIZED HATHA YOGA EFFECTS ON THE VASCULAR INFLAMMATION FACTORS OF ELDERLY WOMEN. [PURPOSE] THE AIM OF THIS STUDY WAS TO EXAMINE THE EFFECTS OF THE APPLICATION OF ELDERLY-CUSTOMIZED HATHA YOGA ON THE VASCULAR INFLAMMATION FACTORS OF ELDERLY WOMEN. [SUBJECTS AND METHODS] THIS RESEARCH WAS CONDUCTED WITH 14 ELDERLY WOMEN, BETWEEN 70 AND 80 YEARS OLD, DIVIDED INTO AN ELDERLY-CUSTOMIZED HATHA YOGA GROUP (N=7) AND A CONTROL GROUP (N=7). THE APPLICATION GROUP PARTICIPATED IN A HATHA YOGA PROGRAM DESIGNED TO BE ELDERLY-FRIENDLY FOR 10 WEEKS. AT THE END OF THE PROGRAM, THE VASCULAR INFLAMMATION FACTORS WERE MEASURED, INCLUDING THE ALBUMIN, WHITE BLOOD CELL COUNT, FIBRINOGEN, HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP), AND ERYTHROCYTE SEDIMENTATION RATE (ESR). [RESULTS] IN THE HATHA YOGA GROUP, THE ALBUMIN INCREASED SIGNIFICANTLY AFTER THE APPLICATION, WHEN COMPARED TO THE LEVEL BEFORE THE APPLICATION, WHILE THE FIBRINOGEN, HS-CRP, AND ESR DECREASED SIGNIFICANTLY. IN THE CONTROL GROUP, THE VASCULAR INFLAMMATION FACTOR LEVELS BEFORE AND AFTER THE APPLICATION PERIOD WERE NOT SIGNIFICANTLY DIFFERENT. [CONCLUSION] BASED ON THE RESULTS OF THIS STUDY, THE APPLICATION OF ELDERLY-CUSTOMIZED HATHA YOGA CREATED POSITIVE CHANGES IN THE VASCULAR INFLAMMATION FACTORS OF ELDERLY WOMEN. 2017 4 1122 28 EFFICACY OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA--A SELF CONTROLLED MATCHED SCIENTIFIC STUDY. ASTHMA IS ONE OF THE COMMON PSYCHOSOMATIC ILLNESS INFLUENCED BY MANY FACTORS. BRONCHODILATORS GIVE TEMPORARY RELIEF AND HAVE SIDE EFFECTS. THE PRESENT STUDY IS AIMED AT FINDING THE EFFICACY OF A NON-PHARMACOLOGICAL APPROACH OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA. A TOTAL NO OF 37 PATIENTS (19 MEN, 18 WOMEN) WITH MEAN AGE 35.06 YRS (MEN), 40.74 YRS (WOMEN) ADMITTED TO INYS, BANGALORE, FOR THE PERIOD OF 21 DAYS. THE TREATMENT INCLUDED 1. DIET THERAPY 2. NATURE CURE TREATMENT AND 3. YOGA THERAPY. THE VARIOUS PARAMETERS INCLUDING LUNG FUNCTION TEST WERE MEASURED ON ADMISSION AND ONCE A WEEK. RESULTS SHOWED THE SIGNIFICANT IMPROVEMENT IN PEFR, VC, FVC, FEV1, FEV/FEC %, MVV, ESR AND ABSOLUTE EOSINOPHIL COUNT. THE PATIENTS REPORTED A FEELING OF WELL BEING, FRESHNESS AND COMFORTABLE BREATHING. NATUROPATHY AND YOGA HELPS IN INDUCING POSITIVE HEALTH, ALLEVIATING THE SYMPTOMS OF DISEASE BY ACTING AT PHYSICAL AND MENTAL LEVELS. 2001 5 281 28 ADHERENCE TO AND CHANGES IN MENTAL AND PHYSIOLOGICAL HEALTH DURING AN 8-WEEK YOGA INTERVENTION: A PILOT STUDY. BACKGROUND: PARTICIPATING IN YOGA MAY BE IDEAL FOR COLLEGE STUDENTS TO INCREASE PHYSICAL ACTIVITY AND IMPROVE MENTAL HEALTH. PURPOSE: TO INVESTIGATE THE FEASIBILITY AND IMPACT OF AN 8-WEEK YOGA INTERVENTION WITHIN A UNIVERSITY SETTING ON MENTAL AND PHYSIOLOGIC HEATH. METHODS: THIS 8-WEEK YOGA INTERVENTION INCLUDED TWELVE YOGA-NAIVE ADULTS, (23.8 +/- 4.6 YEARS; 71% FEMALE). PARTICIPANTS ATTENDED TWO 60-MIN YOGA CLASSES/WEEK IN ADDITION TO BASELINE, MID- AND POST-LAB VISITS. RESULTS: 83% OF PARTICIPANTS ATTENDED >/=75% OF YOGA CLASSES. STRESS AND DEPRESSION SYMPTOMS DECREASED BY 11% AND 25%, RESPECTIVELY AND ERYTHROCYTE SEDIMENTATION RATE (ESR) REDUCED BY 28%. PARTICIPANTS WHO DID NOT MEET PHYSICAL ACTIVITY RECOMMENDATIONS OBSERVED GREATER IMPROVEMENTS IN STRESS, DEPRESSION SYMPTOMS, ESR, AND C-REACTIVE PROTEIN COMPARED TO PARTICIPANTS WHO MET RECOMMENDATIONS. CONCLUSION: THE MAJORITY OF PARTICIPANTS ATTENDED >/=12 OF 16 YOGA CLASSES. EXPLORATORY ANALYSES PROVIDE PRELIMINARY SUPPORT FOR THE IMPACT OF YOGA ON REDUCING STRESS, SYMPTOMS OF DEPRESSION, AND ESR. PARTICIPANTS WHO WERE NOT MEETING PHYSICAL ACTIVITY GUIDELINES PRIOR TO STARTING THE INTERVENTION RECEIVED GREATER BENEFITS. 2022 6 2783 35 YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT OF SYSTEMIC SCLEROSIS: A CASE SERIES. SYSTEMIC SCLEROSIS (SSC) IS AN AUTOIMMUNE DISORDER LEADING TO SIGNIFICANT DISABILITY AND LOSS OF QUALITY OF LIFE (QOL). YOGA HAS BECOME POPULAR IN RECENT TIMES FOR ITS POTENTIAL THERAPEUTIC BENEFITS. SINCE THERE ARE NO SCIENTIFIC REPORTS ON THE USE OF YOGA FOR SSC, WE PRESENT TWO FEMALE CASES (AGED 49 AND 29 RESPECTIVELY) OF LIMITED SSC (DURATION OF ILLNESS 4 AND 3 YEARS RESPECTIVELY) WHO UNDERWENT YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT IN A RESIDENTIAL SETTING FOR A PERIOD OF FIVE AND FOUR WEEKS, RESPECTIVELY. DURING THEIR STAY, THEY UNDERWENT A SPECIFICALLY DESIGNED YOGA MODULE. AFTER THEIR DISCHARGE, THEY WERE FOLLOWED-UP FOR FOUR WEEKS, DURING WHICH THEY WERE ASKED TO CONTINUE PRACTICING YOGA FOR 1 H EVERY DAY. BOTH OF THEM REPORTED A REDUCTION IN PAIN, STIFFNESS, SYMPTOM SCORES, AND IMPROVED QOL ON DISCHARGE AND AT THE FOLLOW-UP COMPARED TO THE VALUES ON ADMISSION. ERYTHROCYTE SEDIMENTATION RATE (ESR) AND C-REACTIVE PROTEIN (CRP), AS BIOMARKERS OF INFLAMMATION, REDUCED ON THE DISCHARGE WHEN COMPARED TO THE BASELINE. NO ADVERSE EVENTS WERE NOTED DURING THE STAY AND THE FOLLOW-UP. THUS, THE PRESENT CASE SERIES INDICATE A POSSIBLE BENEFICIAL ROLE OF YOGA AS AN ADJUNCT THERAPY TO CONVENTIONAL MANAGEMENT OF SSC. FURTHER STUDIES IN THE AREA ARE WARRANTED TO ASCERTAIN THE EFFICACY OF YOGA FOR SSC. 2021 7 2635 34 YOGA FOR TREATING RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. PURPOSE: RHEUMATOID ARTHRITIS (RA) IS A PERVASIVE INFLAMMATORY AUTOIMMUNE DISEASE THAT SERIOUSLY IMPAIRS HUMAN HEALTH AND REQUIRES MORE EFFECTIVE NON-PHARMACOLOGIC TREATMENT APPROACHES. THIS STUDY AIMS TO SYSTEMATICALLY REVIEW AND EVALUATE THE EFFICACY OF YOGA FOR PATIENTS WITH RA. METHODS: MEDLINE (THROUGH PUBMED), COCHRANE LIBRARY, EMBASE (THROUGH SCOPUS), AND WEB OF SCIENCE DATABASE WERE SCREENED THROUGH FOR ARTICLES PUBLISHED UNTIL 20 JULY 2020. RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA IN PATIENTS WITH RA WERE INCLUDED. OUTCOMES MEASURES WERE PAIN, PHYSICAL FUNCTION, DISEASE ACTIVITY, INFLAMMATORY CYTOKINES, AND GRIP STRENGTH. FOR EACH OUTCOME, STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULT: TEN TRIALS INCLUDING 840 PATIENTS WITH RA AGED 30-70 YEARS WERE IDENTIFIED, WITH 86% FEMALE PARTICIPANTS. META-ANALYSIS REVEALED A STATISTICALLY SIGNIFICANT OVERALL EFFECT IN FAVOR OF YOGA FOR PHYSICAL FUNCTION (HAQ-DI) (5 RCTS; SMD = -0.32, 95% CI -0.58 TO -0.05, I (2) = 15%, P = 0.02), DISEASE ACTIVITY (DAS-28) (4 RCTS; SMD = -0.38, 95% CI -0.71 TO -0.06, I (2) = 41%, P = 0.02) AND GRIP STRENGTH (2 RCTS; SMD = 1.30, 95% CI 0.47-2.13, I (2) = 63%, P = 0.002). NO EFFECTS WERE FOUND FOR PAIN, TENDER JOINTS, SWOLLEN JOINTS COUNT OR INFLAMMATORY CYTOKINES (I.E., CRP, ESR, IL-6, AND TNF-ALPHA). SUMMARY: THE FINDINGS OF THIS META-ANALYSIS INDICATE THAT YOGA MAY BE BENEFICIAL FOR IMPROVING PHYSICAL FUNCTION, DISEASE ACTIVITY, AND GRIP STRENGTH IN PATIENTS WITH RA. HOWEVER, THE BALANCE OF EVIDENCE SHOWED THAT YOGA HAD NO SIGNIFICANT EFFECT IN IMPROVING PAIN, TENDER JOINTS, SWOLLEN JOINTS COUNT, AND INFLAMMATORY CYTOKINES IN PATIENTS SUFFERING FROM RA. CONSIDERING METHODOLOGICAL LIMITATIONS, SMALL SAMPLE SIZE, AND LOW-QUALITY, WE DRAW A VERY CAUTIOUS CONCLUSION IN THE RESULTS OF THE ESTIMATE OF THE EFFECT. HIGH-QUALITY AND LARGE-SCALE RCTS ARE URGENTLY NEEDED IN THE FUTURE, AND THE REAL RESULT MAY BE SUBSTANTIALLY DIFFERENT. 2020 8 1395 48 IMPACT OF YOGA BASED MIND-BODY INTERVENTION ON SYSTEMIC INFLAMMATORY MARKERS AND CO-MORBID DEPRESSION IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: RECOVERY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) DEPENDS ON SEVERAL PHYSICAL AND PSYCHOLOGICAL FACTORS, BESIDES PHARMACOLOGICAL TREATMENT. CO-MORBID DEPRESSION ADVERSELY AFFECTS THE OUTCOME IN RA. USUAL MEDICAL THERAPIES HAVE A LIMITED SCOPE AND FAIL TO CURE THE PSYCHOLOGICAL COMPONENT OF THE DISEASE. WITH ADVANCED THERAPEUTIC OPTIONS, ACHIEVING A STATE OF REMISSION HAS BECOME THE TREATMENT GOAL, YOGA BASED MIND BODY INTERVENTION (MBI) MAY PROVIDE A HOLISTIC APPROACH IN ITS TREATMENT DIMENSION. HENCE, MBIS ARE THE NEED OF HOUR AS MAJORITY OF DISEASES HAVE A PSYCHOSOMATIC COMPONENT. OBJECTIVE: TO EXPLORE THE EFFECT OF YOGA BASED MBI ON DISEASE SPECIFIC INFLAMMATORY MARKERS AND DEPRESSION SEVERITY IN ACTIVE RA PATIENTS ON ROUTINE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) THERAPY. METHODS: A TOTAL OF 72 RA PATIENTS WERE RANDOMIZED INTO 2 GROUPS: YOGA GROUP (YOGA WITH DMARDS) AND CONTROL GROUP (DMARDS ONLY). BLOOD SAMPLES WERE COLLECTED PRE AND POST INTERVENTION FOR PRIMARY OUTCOME MEASUREMENTS OF SYSTEMIC BIOMARKERS. DISEASE ACTIVITY SCORE 28, ERYTHROCYTE SEDIMENTATION RATE (DAS28ESR) AND HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX (HAQ-DI) WERE USED TO ASSESS DISEASE ACTIVITY AND FUNCTIONAL STATUS RESPECTIVELY AT PRE AND POST INTERVENTION TIME-POINTS. SECONDARY OUTCOME, DEPRESSION SEVERITY, WAS ASSESSED BY BECK DEPRESSION INVENTORY II SCALE (BDI-II) AT 2 WEEKLY INTERVALS DURING 8 WEEKS OF THE STUDY INTERVENTIONAL PLAN. RESULTS: AFTER 8 WEEKS OF YOGA BASED MBI, THERE WAS SIGNIFICANT DECREASE IN THE SEVERITY OF RA AS SEEN BY REDUCTION IN LEVELS OF VARIOUS SYSTEMIC INFLAMMATORY MARKERS AS WELL AS IN DAS28ESR (P-VALUE <0.0001; EFFECT SIZE = 0.210) AND HAQ-DI (P-VALUE 0.001; EFFECT SIZE = 0.159). ALSO, YOGA GROUP EXPERIENCED A STATISTICALLY SIGNIFICANT TIME DEPENDENT STEP-WISE DECLINE IN DEPRESSION SYMPTOMS OVER THE PERIOD OF 8 WEEKS AS COMPARED TO CONTROL GROUP (P-VALUE <0.0001; EFFECT SIZE = 0.5). REGRESSION ANALYSIS SHOWED GREATER REDUCTION IN THE SCORES OF BDI-II WITH DAS28ESR (R2 = 0.426; P < 0.0001) AND HAQ-DI (R2 = 0.236; P = 0.003) IN YOGA GROUP. CONCLUSIONS: YOGA, A MIND BODY INTERVENTION RE-ESTABLISHED IMMUNOLOGICAL TOLERANCE BY AIDING REMISSION AT MOLECULAR AND CELLULAR LEVEL ALONG WITH SIGNIFICANT REDUCTION IN DEPRESSION. THUS IN THIS SEVERE AUTOIMMUNE INFLAMMATORY ARTHRITIS WITH A MAJOR PSYCHOSOMATIC COMPONENT, YOGA CAN BE USED AS A COMPLEMENTARY/ADJUNCT THERAPY. 2019 9 1665 20 NATUROPATHY AND YOGA FOR IMPROVING QUALITY OF LIFE IN PEMPHIGUS VULGARIS AND MANAGING CO-MORBID TYPE 2 DIABETES: A CASE REPORT. A 57 YEARS OLD MALE PATIENT WAS ADMITTED TO AN INPATIENT NATUROPATHY AND YOGA (N&Y) HOSPITAL, DIAGNOSED WITH PEMPHIGUS VULGARIS (PV) FOR ONE YEAR AND CO-MORBID TYPE 2 DIABETES (T2DM) FOR 10 YEARS, ASSOCIATED WITH POOR QUALITY OF LIFE (QOL). HE WAS ADMINISTERED N&Y THERAPIES FOR 10 DAYS, ALONG WITH CONVENTIONAL MEDICINES. THERE WAS IMPROVED QOL AND REDUCED DOSAGE OF INSULIN, ALONG WITH REDUCTION IN BODY WEIGHT. THESE CHANGES WERE SUSTAINED AND IMPROVED FURTHER DURING THE 60-DAY FOLLOW-UP PERIOD. ALTHOUGH THERE WAS NO IMPROVEMENT IN THE SKIN LESIONS, THE IMPROVEMENT IN QOL INDICATE A POSSIBLE ROLE OF N&Y IN MANAGEMENT OF PV AND T2DM. THIS CASE REPORT ALSO WARRANTS FURTHER STUDIES FOR N&Y IN THE MANAGEMENT OF DERMATOLOGICAL CONDITIONS AS WELL AS METABOLIC SYNDROME. 2020 10 2803 17 YOGA THERAPY IN CHRONIC BRONCHITIS. FIFTEEN PATIENTS OF CHRONIC BRONCHITIS RECEIVED YOGA THERAPY IN THE FORM OF PRANAYAM AND 8 TYPES OF 'ASANS' FOR A PERIOD OF 4 WEEKS. THEY HAD A PERCEPTIBLE IMPROVEMENT IN DYSPNOEA AS WAS MEASURED BY VISUAL ANALOG. LUNG FUNCTION PARAMETERS (VC, FEV1, AND PEFR) ALSO IMPROVED AFTER THE PRACTICE OF YOGA. THIS PRELIMINARY STUDY INDICATES THAT, YOGA MAY BE AN USEFUL ADJUNCT TO OTHER CONVENTIONAL FORM OF THERAPY FOR COPD. 1998 11 2199 30 THE EFFICACY OF TAI CHI AND YOGA IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHROPATHIES: A NARRATIVE BIOMEDICAL REVIEW. RHEUMATOID ARTHRITIS (RA) AND SPONDYLOARTHROPATHIES (SPA) ARE AMONG THE MOST COMMON INFLAMMATORY RHEUMATIC DISEASES, WHICH MIGHT INDUCE CHRONIC PAIN FOR THEIR SUFFERERS. MIND-BODY INTERVENTIONS LIKE TAI CHI AND YOGA ARE AMONG THE MANY ALTERNATIVE THERAPIES FOR COMBATTING CHRONIC PAIN. THIS REVIEW AIMS TO OVERVIEW THE ARTICLES ABOUT THEIR EFFECTIVENESS IN RA AND SPA. WE SEARCHED PUBMED/MEDLINE, SCOPUS, AND WEB OF SCIENCE FOR ENGLISH-LANGUAGE SOURCES FROM THEIR INCEPTION THROUGH SEPTEMBER 2017. CASE-CONTROL STUDIES, INTERVENTIONAL STUDIES, AND CASE SERIES THAT INCLUDED MORE THAN THREE CASES AND RANDOMIZED CROSSOVER STUDIES WERE INCLUDED. THE LITERATURE SEARCH RETRIEVED 133 NON-DUPLICATE RECORDS, AND 15 OF THEM WERE ELIGIBLE AND WERE INCLUDED IN THIS REVIEW. THE INFLUENCE OF TAI CHI REMAINS DEBATABLE IN RA, WHILE THERE IS ONLY ONE STUDY THAT INVESTIGATED ITS EFFICACY IN SPA. YOGA SEEMS EFFECTIVE IN DECREASING PAIN AND INFLAMMATION WHILE INCREASING QUALITY OF LIFE. THERE ARE NO DATA AVAILABLE ABOUT ITS EFFECT ON SPA. EVEN AFTER A THOROUGH RESEARCH, THE NUMBER OF ARTICLES IS QUITE LIMITED ON THE EFFECTIVENESS OF TAI CHI AND YOGA IN RA AND SPA. WHILE THESE COMPLEMENTARY APPROACHES STILL SHOW SOME PROMISE AS ALTERNATIVE THERAPIES IN RA AND SPA, THE LITERATURE LACKS LONG-TERM STUDIES WITH LARGER PATIENT GROUPS. 2018 12 2059 26 THE BENEFITS OF YOGA FOR RHEUMATOID ARTHRITIS: RESULTS OF A PRELIMINARY, STRUCTURED 8-WEEK PROGRAM. THE AIM OF THIS STUDY WAS TO MEASURE THE EFFECTS OF A BI-WEEKLY RAJ YOGA PROGRAM ON RHEUMATOID ARTHRITIS (RA) DISEASE ACTIVITY. SUBJECTS WERE RECRUITED FROM AMONG RA PATIENTS IN DUBAI, UNITED ARAB EMIRATES BY EMAIL INVITATIONS OF THE RA DATABASE. DEMOGRAPHIC DATA, DISEASE ACTIVITY INDICES, HEALTH ASSESSMENT QUESTIONNAIRE (HAQ), AND QUALITY OF LIFE (QOL) BY SF-36 WERE DOCUMENTED AT ENROLLMENT AND AFTER COMPLETION OF 12 SESSIONS OF RAJ YOGA. A TOTAL OF 47 PATIENTS WERE ENROLLED: 26 YOGA AND 21 CONTROLS. BASELINE DEMOGRAPHICS WERE SIMILAR IN BOTH GROUPS. PATIENTS WHO UNDERWENT YOGA HAD STATISTICALLY SIGNIFICANT IMPROVEMENTS IN DAS28 AND HAQ, BUT NOT QOL. OUR PILOT STUDY OF 12 SESSIONS OF YOGA FOR RA WAS ABLE TO DEMONSTRATE STATISTICALLY SIGNIFICANT IMPROVEMENTS IN RA DISEASE PARAMETERS. WE BELIEVE THAT A LONGER DURATION OF TREATMENT COULD RESULT IN MORE SIGNIFICANT IMPROVEMENTS. 2009 13 718 18 EFFECT OF INTEGRATIVE NATUROPATHY AND YOGA IN A PATIENT WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH TYPE 2 DIABETES AND HYPERTENSION. A 54-YEAR OLD MARRIED WOMAN WAS DIAGNOSED WITH RHEUMATOID ARTHRITIS IN 2002, ESSENTIAL HYPERTENSION IN 2008, TYPE-2 DIABETES IN 2011 AND GANGRENE OVER 2(ND) TOE OF RIGHT FOOT. SHE UNDERWENT CONVENTIONAL MANAGEMENT IN PRIVATE HOSPITALS. HER SYMPTOMS, BEGAN WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH SWELLING, STIFFNESS (MORE IN THE MORNING) IN MULTIPLE JOINTS ESPECIALLY OVER SMALL JOINTS. IN JULY-2014 SHE VISITED OUR COLLEGE HOSPITAL WITH THE COMPLAINTS OF PAIN, MILD SWELLING AND STIFFNESS OVER MULTIPLE JOINTS ASSOCIATED WITH POOR QUALITY OF SLEEP (QOS) AND QUALITY OF LIFE (QOL). SUBJECT RECEIVED INTEGRATIVE NATUROPATHY AND YOGA THERAPIES (INYT) WITH CONVENTIONAL MEDICINE DAILY FOR 10-DAYS. AFTER 10-DAYS, IMPROVEMENTS IN PAIN, BLOOD SUGAR, DEPRESSION, ANXIETY, STRESS, QOS, QOL, BLOOD ANALYSIS WITH NORMAL BLOOD PRESSURE (BP) WAS OBSERVED. THIS SUGGESTS THAT INYT COULD BE CONSIDERED AS AN ADJUVANT TO CONVENTIONAL MEDICINE IN RA ASSOCIATED WITH TYPE-2 DIABETES AND ESSENTIAL HYPERTENSION. 2017 14 2793 23 YOGA THERAPY FOR FIBROMYALGIA SYNDROME: A CASE REPORT. FIBROMYALGIA IS A RHEUMATOLOGIC SYNDROME LEADING TO INCREASED PAIN SENSITIVITY, SLEEP DISTURBANCE, FATIGUE, STIFFNESS, AND TENDERNESS OF JOINTS, MUSCLES, AND TENDONS DUE TO DYSREGULATION OF NEUROPHYSIOLOGICAL FUNCTIONS. IN THE PRESENT CASE REPORT, A 42-YEAR-OLD, NON-INDIAN, NONSMOKING, NONALCOHOLIC, FEMALE PRESENTED WITH COMPLAINTS OF SEVERE DIFFICULTY IN WALKING, JOINT PAINS, AND GENERALIZED LOSS OF BALANCE OF THE BODY. THE PATIENT WAS AN ESTABLISHED CASE OF FIBROMYALGIA. THE TREATMENT PLAN FOR THE PATIENT INCLUDED 9 MONTHS OF YOGA THERAPY. NO CONCOMITANT ALLOPATHIC MEDICATION WAS GIVEN DURING THIS WHOLE TREATMENT PERIOD. THE PATIENT WAS GIVEN SPECIAL YOGA POSTURES TO IMPROVE FLEXIBILITY AND MOVEMENT OF JOINTS, DAILY 1 HOUR, 6 DAYS/WEEK IN THE MORNING, AND EVENING FOR 9 MONTHS. THE MUSCLE FATIGUE, QUALITY OF LIFE AND SLEEP WAS ASSESSED AT THE BASELINE, 3(RD), 6(TH), AND 9(TH) MONTH. THE RESULT OF PRESENT CASE STUDY DEMONSTRATED REDUCTION IN MUSCLE FATIGUE AND IMPROVEMENT IN QUALITY OF LIFE AND SLEEP. 2020 15 2475 25 YOGA AS AN ADJUNCT FOR MANAGEMENT OF OPIOID DEPENDENCE SYNDROME: A NINE-MONTH FOLLOW-UP CASE REPORT. OPIOID DEPENDENCE SYNDROME (ODS) IS A CHRONIC RELAPSING REMITTING CONDITION ASSOCIATED WITH SIGNIFICANT IMPAIRMENT AND MORTALITY RISK. OPIOID SUBSTITUTION THERAPY IS USED WORLDWIDE, BUT LONG-TERM RETENTION RATES ARE LOW AND THERE IS RISK OF MISUSE AND DIVERSION. YOGA PRACTICE CAN IMPROVE QUALITY OF LIFE, REDUCE CHRONIC PAIN, AND ENHANCE ENDOGENOUS OPIOIDS (BETA-ENDORPHINS). WE DESCRIBE A CASE OF ODS WHERE YOGA WAS ADDED TO THE CONVENTIONAL MANAGEMENT AND WHO WAS FOLLOWED UP FOR 9 MONTHS. ASSESSMENTS WERE DONE FOR CLINICAL SYMPTOMS, URINE DRUG SCREENING, PLASMA BETA-ENDORPHINS, AND BUPRENORPHINE DOSAGE. WE OBSERVED AN IMPROVEMENT IN HIS CLINICAL SYMPTOMS AND REDUCTION IN THE REQUIREMENTS FOR BUPRENORPHINE. A SLIGHT INCREASE IN BASAL PLASMA BETA-ENDORPHIN LEVELS WAS ALSO OBSERVED AT THE 9-MONTH FOLLOW-UP (FROM 2.02 PMOL/L AT BASELINE TO 6.51 PMOL/L). 2021 16 856 22 EFFECT OF YOGA ON THE QUALITY OF LIFE OF PATIENTS WITH RHEUMATIC DISEASES: SYSTEMATIC REVIEW WITH META-ANALYSIS. AIM: TO ANALYZE THE EFFECTS OF YOGA ON THE QUALITY OF LIFE OF PATIENTS WITH RHEUMATIC DISEASES THROUGH A SYSTEMATIC REVIEW WITH META-ANALYSIS. METHODS: THIS SYSTEMATIC REVIEW WITH META-ANALYSIS WAS CONDUCTED FOLLOWING THE RECOMMENDATIONS OF THE DECLARATION OF PRISMA. THE SEARCHES WERE CARRIED OUT ON THE DATABASES PUBMED, WEB OF SCIENCE, EBSCO, SCOPUS, AND COCHRANE UNTIL AUGUST 2018. EXPERIMENTAL STUDIES EVALUATING THE EFFECT OF YOGA ON THE QUALITY OF LIFE IN PATIENTS WITH RHEUMATIC DISEASES WERE INCLUDED. RESULTS: AFTER DATA SEARCHES, 483 STUDIES WERE FOUND, 23 OF WHICH WERE INCLUDED IN OUR ANALYSIS. WE FOUND THAT YOGA IMPROVES THE OVERALL QUALITY OF LIFE (D= -0.64; 95% CI: -0.91 TO 0.038) OF PATIENTS WITH RHEUMATIC DISEASES, AS WELL AS THE FOLLOWING DOMAINS: FUNCTIONAL CAPACITY (D=16.43; 95% CI: 13.37-19.49), PHYSICAL ASPECTS (D=27.11; 95% CI: 19.40-34.83), EMOTIONAL ASPECTS (D=26.00; 95% CI: 18.87-33.13), GENERAL HEALTH (D=16.61; 95% CI: 12.66-20.55), AND SOCIAL ASPECTS (D=7.01 ; 95% CI: 5.57-9.45). CONCLUSION: EVIDENCE SUGGESTS WEAK RECOMMENDATIONS CAN BE MADE FOR THE USE OF YOGA IN THE MANAGEMENT OF RD PATIENTS. 2019 17 2624 41 YOGA FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): CLINICIAN EXPERIENCES AND QUALITATIVE PERSPECTIVES FROM STUDENTS AND YOGA INSTRUCTORS LIVING WITH SLE. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS AN AUTOIMMUNE DISEASE ASSOCIATED WITH WIDESPREAD INFLAMMATION AND TISSUE DAMAGE. IT IS MORE COMMON AND SEVERE AMONG BLACKS, HISPANICS, AND ASIANS; WITH HIGHER INCIDENCE IN WOMEN. WHILE THE GOALS OF MEDICAL TREATMENT ARE TO PREVENT FLARES AND REDUCE ORGAN DAMAGE, UP TO 50% OF PATIENTS PERCEIVE THEIR HEALTH TO BE SUBOPTIMAL WITH UNADDRESSED NEEDS INCLUDING FATIGUE AND PAIN. RECENT SLE TREATMENT GUIDELINES FOCUS ON IMPROVING QUALITY OF LIFE. YOGA HAS SHOWN IMPROVEMENTS IN QUALITY-OF-LIFE AND FATIGUE IN VARIOUS DIAGNOSES. WHILE THERE IS GROWING EVIDENCE THAT YOGA THERAPY MAY HELP OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS SYMPTOMS, THERE IS ONLY ONE REFERENCE IN THE LITERATURE RELATED TO SLE. METHODS/SETTING: AN ADJUNCT STUDY WAS UNDERTAKEN TO EVALUATE ADAPTING THE YOGA AS SELF CARE FOR ARTHRITIS IN MINORITY COMMUNITIES STUDY FOR A BILINGUAL POPULATION LIVING WITH SLE IN THE WASHINGTON, DC AREA. INFORMANTS INCLUDED 7 PATIENTS ENROLLED ONTO THE STUDY, AND 3 YOGA INSTRUCTORS LIVING WITH SLE. QUALITATIVE METHODS INCLUDED JOURNALS AND SEMI-STRUCTURED INTERVIEWS. RESULTS: ENROLLING PATIENTS CLARIFIED REVISIONS FOR INTAKE QUESTIONNAIRES, AND SYMPTOMS THAT MAY IMPACT CLASS PARTICIPATION. PARTICIPANTS DEMONSTRATED INCREASED BALANCE, BODY AWARENESS, AND TOLERATED A FASTER-PACED YOGA CLASS WHEN COMPARED TO THOSE IN THE PARENT STUDY. YOGA INSTRUCTORS' RECOMMENDATIONS INCLUDED MODIFYING YOGA BASED ON ENERGY LEVELS AND FREQUENT CHANGES IN PHYSICAL ABILITY. CONCLUSION: THIS PAPER SHARES PERSPECTIVES FROM VARIOUS INFORMANTS AND AFFIRMS THE FEASIBILITY OF PROGRESSING TO A LARGER STUDY. IT SUMMARIZES OUR FINDINGS AND RECOMMENDATIONS TOWARDS CREATING A RANDOMIZED CONTROLLED TRIAL, AS THERE ARE CURRENTLY NONE IN THE LITERATURE. 2018 18 798 36 EFFECT OF YOGA LIFESTYLE IN PATIENTS WITH HEART FAILURE: A RANDOMIZED CONTROL TRIAL. BACKGROUND: IN SPITE OF SIGNIFICANT ADVANCES IN THE MANAGEMENT OF HEART FAILURE (HF), MORBIDITY AND MORTALITY REMAIN HIGH. THEREFORE, THERE IS A NEED FOR ADDITIONAL STRATEGIES. WE DID A RANDOMIZED CLINICAL TRIAL TO STUDY EFFECT OF YOGA IN PATIENTS WITH HF IN TERMS OF QUALITY OF LIFE (QOL), LEFT VENTRICLE EJECTION FRACTION (LVEF), C-REACTIVE PROTEIN (CRP), AND NTPROBNP. MATERIALS AND METHODS: 60 PATIENTS WITH STABLE HF NEW YORK HEART ASSOCIATION CLASS II WITH LVEF 30%-40% WERE RANDOMIZED INTO CONTROL GROUP (CG) AND YOGA GROUP (YG). CG RECEIVED THE GUIDELINE-BASED THERAPY AND YG IN ADDITION PRACTICED THE YOGA, ONE HOUR DAILY FOR 3 MONTHS. ALL PATIENTS WERE ASSESSED FOR QOL, CRP, NTPROBNP, AND LVEF AT BASELINE AND AFTER 3 MONTHS. RESULTS: A SIGNIFICANT DIFFERENCE WAS OBSERVED IN ALL FOUR PARAMETERS IN THE YG AS COMPARED TO THE CG (P < 0.01) AFTER 12 WEEKS. QOL AS ASSESSED BY MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE SCORE IMPROVED SIGNIFICANTLY IN YG AS COMPARED TO CG (10 V/S 14, P < 0.001). THERE WAS A SIGNIFICANT IMPROVEMENT WITHIN YG IN TERMS OF LVEF (33.4-36.8, P = 0.001), AND THE PERCENTAGE CHANGE IN LVEF WAS SIGNIFICANT BETWEEN THE GROUPS (10% V/S 5%, P = 0.001). NTPROBNP ALSO SIGNIFICANTLY REDUCED BY 69.8% FROM 755 TO 220 PMOL/L IN YG AS COMPARED TO 39.3% IN CG (679-406 PMOL/L). CRP DECREASED BY 49.3% (5.36-2.73 MG/L) IN YG AND 35.8% (5.39-3.45 MG/L) IN CG. CONCLUSION: THE RESULT OF THIS PILOT STUDY SUGGESTS THAT ADDITION OF YOGA TO GUIDELINE-BASED THERAPY FOR HF PATIENTS SIGNIFICANTLY IMPROVES QOL, LVEF, AND NTPROBNP AND REDUCES CRP LEVEL. LARGER STUDIES ARE NEEDED TO CONFIRM THESE FINDINGS. 2022 19 1066 33 EFFECTS OF YOGA ON INFLAMMATION AND EXERCISE CAPACITY IN PATIENTS WITH CHRONIC HEART FAILURE. BACKGROUND: DESPITE RECENT ADVANCES IN PHARMACOLOGIC AND DEVICE THERAPY, MORBIDITY AND MORTALITY FROM HEART FAILURE (HF) REMAIN HIGH. YOGA COMBINES PHYSICAL AND BREATHING EXERCISES THAT MAY BENEFIT PATIENTS WITH HF. WE HYPOTHESIZED THAT AN 8-WEEK REGIMEN OF YOGA IN ADDITION TO STANDARD MEDICAL THERAPY WOULD IMPROVE EXERCISE CAPACITY, INFLAMMATORY MARKERS, AND QUALITY OF LIFE (QOL) IN PATIENTS WITH HF. METHODS AND RESULTS: NEW YORK HEART ASSOCIATION CLASS I-III HF PATIENTS WERE RANDOMIZED TO YOGA TREATMENT (YT) OR STANDARD MEDICAL THERAPY (MT). MEASUREMENTS INCLUDED A GRADED EXERCISE TEST (GXT) TO V O(2PEAK) AND THE FOLLOWING SERUM BIOMARKERS: INTERLEUKIN-6 (IL-6), HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP), AND EXTRACELLULAR SUPEROXIDE DISMUTASE (EC-SOD). THE MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE (MLHFQ) WAS ADMINISTERED TO ASSESS CHANGES IN QOL. A TOTAL OF 19 PATIENTS WERE ENROLLED AFTER THE INITIAL SCREENING. OF THE 19 PATIENTS, 9 WERE RANDOMIZED TO YT AND 10 TO MT. PATIENTS HAD A MEAN EF OF 25%. GXT TIME AND V O(2PEAK) WERE SIGNIFICANTLY IMPROVED IN THE YT VERSUS MT GROUPS (+18% IN THE YT AND -7.5% IN MT; P = .03 VS. CONTROL AND +17 IN YT AND -7.1 IN MT; P = .02, RESPECTIVELY). THERE WERE STATISTICALLY SIGNIFICANT REDUCTIONS IN SERUM LEVELS OF IL-6 AND HSCRP AND AN INCREASE IN EC-SOD IN THE YT GROUP (ALL P < .005 VS. MT). MLHFQ SCORES IMPROVED BY 25.7% IN THE YT GROUP AND BY 2.9% IN THE MT GROUP. CONCLUSIONS: YOGA IMPROVED EXERCISE TOLERANCE AND POSITIVELY AFFECTED LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH HF, AND THERE WAS ALSO A TREND TOWARD IMPROVEMENTS IN QOL. 2008 20 1448 24 INDIVIDUALLY TAILORED YOGA FOR CHRONIC NECK OR BACK PAIN IN A LOW-INCOME POPULATION: A PILOT STUDY. BACKGROUND: LOW-INCOME PEOPLE ARE DISPROPORTIONATELY AFFECTED BY CHRONIC BACK AND NECK PAIN. YOGA MAY BE AN EFFECTIVE THERAPY. AIMS: THIS FEASIBILITY PILOT STUDY EVALUATED AN INDIVIDUALIZED YOGA PLAN FOR THE TREATMENT OF CHRONIC SPINAL PAIN. METHODS: RESULTS: INDIVIDUALS SHOWED A MEAN CHANGE OF -2.4 FROM PRE/POST 10-CM PAIN SCALE RECORDINGS (P = 0.028, 95% CONFIDENCE INTERVAL [CI]: -0.390--4.477) AND A MEAN INCREASE OF 0.26 ON THE EQ-5D-3L (P = 0.029, 95% CI: 0.04-0.47). THE INTERVENTION WAS WELL-RECEIVED. CONCLUSIONS: AN INDIVIDUALLY TAILORED YOGA PROGRAM WAS ACCEPTABLE TO THESE PARTICIPANTS. PAIN AND QUALITY OF LIFE SCORES APPEARED TO IMPROVE. 2020